Compound
D1255 | HPP+
| Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| ELECTRON TRANSPORT CHAIN | 15 μM | NADH–Q-1 | decrease | IC50 | 119 | |||
| Target | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| NADH:ubiquinone reductase | 15 μM | NADH–Q-1 | inhibitor | IC50 | 119 | |||
| 4-(4-Chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)pyridinium | 4-(4-Chlorophenyl)-1-(4-(fluorophenyl)-4-oxobutyl)pyridium | 4-(4-Chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-pyridinium (HPP+) |
| 4-Cfobp | 47Z7A2W953 | Bcpp(+) |
| CHEMBL1269 | Hpp(+) | Pyridium, 4-(4-chlorophenyl)-1-(4-(fluorophenyl)-4-oxobutyl)- |
| Q27259091 | SCHEMBL13385512 | UNII-47Z7A2W953 |
| haloperidol pyridinium |